atomoxetine

atomoxetine

« Back to Glossary Index

Atomoxetine (Strattera, Attera, Attentin, Axepta, Axetra, Stramox, Tomoxetin) is a non-stimulant medication approved by the U.S. FDA in 2002 to treat attention-deficit hyperactivity disorder (ADHD). It belongs to the group of medicines called selective norepinephrine reuptake inhibitors (NRIs), and is believed to work by increasing norepinephrine and dopamine. It increases wakefulness, but generally less strongly than the medications which act directly on dopamine. A medication similar to atomoxetine is reboxetine, which is approved in Europe but is not currently approved in the U.S. However, reboxetine was granted Orphan Drug Designation (ODD) status by the FDA in October 2018 for the treatment of narcolepsy. Read more about atomoxetine at MedlinePlus.gov HERE and on HF’s Treatment web page HERE.

Synonyms:
Strattera, Attera, Attentin, Axepta, Axetra, Stramox, Tomoxetin


Get SomnusNooze, our e-newsletter

Sign up to receive HF updates, news from the world of sleep research, first-person stories, and more.

You will receive and email from (please check your junk/spam folder if needed) to confirm your subscription to our newsletter through MailChimp. You are not subscribed until you confirm. Thank you for your interest in Hypersomnia Foundation!